Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emerging Botanicals Present Potential Market Opportunities – ABC

This article was originally published in The Tan Sheet

Executive Summary

Another wave of newly developed plant derivatives as well as new uses for existing botanical and herbal products are being recognized for possible health benefits, according to the American Botanical Council's Mark Blumenthal

You may also be interested in...



Adding Supplements to Federal Support Programs Needs Industry Push – NPA

Exclusion of supplements, along with some congressional resistance to food-stamp coverage for vitamins, supplements, may lead industry to push harder for adding its products to federal support programs, NPA says.

Adding Supplements to Federal Support Programs Needs Industry Push – NPA

A proposal to exclude vitamin D supplementation from a federal nutrition program and continued apathy in Congress toward adding multivitamins and dietary supplements to the food stamp program are signals it is time for the industry to push harder for change, a Natural Products Association executive says

Adding Supplements to Federal Support Programs Needs Industry Push – NPA

A proposal to exclude vitamin D supplementation from a federal nutrition program and continued apathy in Congress toward adding multivitamins and dietary supplements to the food stamp program are signals it is time for the industry to push harder for change, a Natural Products Association executive says

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101107

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel